Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus
Therapeutic Category
Antibacterials, Antibiotic, General and OTC medicines, Gastroenterology, Pediatrics
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*1*10
Price
₹262/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxyplit CV 625 LB containing Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus Tablets represents a highly sought-after and modern solution in the Indian antibiotic market. This combination is a strategic addition to any PCD pharma franchise or B2B pharma business.This unique selling point makes it a premium and highly desirable product for doctors and end-users, ensuring strong demand and repeat sales for our pharma distributors.
By partnering with Cafoli Lifecare, you're not just getting a product; you're getting a bestselling antibiotic with a built-in advantage. We offer this high-quality formulation at competitive rates, ensuring you have the best product to resell at a profitable margin. This is an ideal product for those seeking a profitable PCD franchise with a product that stands out in the market.
Moxyplit CV 625 LB Tablet is primarily used to treat infections such as respiratory tract infections (e.g., pneumonia, bronchitis), urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Its dual action makes it an effective option for patients needing both antibiotic therapy and support for digestive health during treatment.
Common side effects may include nausea, vomiting, diarrhea, or indigestion. If these side effects become severe, contact your doctor promptly.
Moxyplit CV 625 LB Tablet Treats bacterial infections while preventing antibiotic-associated diarrhea; effective in respiratory, urinary, skin, and soft tissue infections.
Information regarding the use of Moxyplit CV 625 Tablet during breastfeeding is not available. Please consult your doctor.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Amoxycillin (875mg) + Clavulanic Acid (125mg)
Composition : Azithromycin (100mg) Tablet
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Azithromycin (250mg) Tablet
Composition : Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Composition : Azithromycin (500mg) + Lactic acid bacillus (60Million spores) Tablet
Composition : Amoxicillin 250mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This advanced antibiotic and probiotic combination tablet has strong demand in the anti-infective and gastrointestinal care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on infection management portfolios.
Medical distributors and agencies can benefit from consistent demand for treatment of respiratory tract infections, urinary tract infections, sinus infections, dental infections, skin infections, and other bacterial infections. Amoxycillin helps eliminate bacteria, Clavulanic Acid improves antibiotic effectiveness by overcoming resistance, while Lactobacillus helps maintain healthy gut flora and reduce antibiotic-associated digestive disturbances, strengthening a comprehensive anti-infective product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this antibiotic-probiotic combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong physician prescription demand, growing preference for probiotic-enriched antibiotic therapies, fast-moving anti-infective category, reliable supply chain support, and good margins when partnering for this specialty antibiotic product.
Medical distributors, stockists, and wholesalers interested in this antibiotic-probiotic combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.